Octagon Therapeutics
Cambridge
About Octagon Therapeutics
Octagon Therapeutics, a preclinical-stage biopharmaceutical company developing antibiotics for multi-drug resistant infections, Octagon has demonstrated effectiveness against the most critical pathogens as identified by the WHO. Octagon World Headquarters is based in the Pagliuca Life Lab directly adjacent to Harvard campus. This state-of-the-art facility has allowed Octagon to accelerate the development of our vital medicines with minimal overhead and equipment costs. Octagon’s management team includes highly skilled scientists, clinicians, and entrepreneurs with decades of research experience and deep expertise in drug development. The scientific team is growing and continues to add top research talent.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Jan 2021)
- Website: octagontherapeutics.com
- Phone: +1 781 910 8518
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/octagon-therapeutics-2451227 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.